GLP-1 receptor agonist (GLP-1RA), a novel hypoglycemic agent, not only promotes insulin synthesis and secretion, but also decreases glucagon secretion in cells while promoting insulin secretion from cells of the pancreas, reduces food intake, and delays gastric emptying
Un impulsor del metabolismo sin estimulacin
[CrossRef] [PubMed] [Google Scholar] Better together
NNMT inhibitor supplied for metabolic and cellular energy studies in laboratory research settings
Download The GLP-1 Transformation in Healthcare, for guidance from industry experts: #wearemedimpact #atruepartner #glp1s #healthcare #employeebenefits #employers #employees #benefits MedImpact Healthcare Systems, Inc
Simply known as liraglutide (the name of the drugs active ingredient), this marks the first generic version of Victoza and one of the first generic versions of a GLP-1 to receive FDA approval